Custom nasal spray at the ready, online allergy treatment startup Allermi is looking to penetrate an underserved consumer market with its first round of funding.
Why it matters: Allermi is focused on a relatively untapped segment of the direct-to-consumer arena: personalized prescription allergy treatment.
It's riding a wave of investor interest jumpstarted by DTC startups including Hims & Hers and Ro.
